Link Expands Series A to 90 Million Dollars
Link Cell Therapies expanded its previously announced $60 million Series A to $90 million. The additional $30 million brings strategic investors including Bristol Myers Squibb and Kyowa Kirin alongside JJDC, Samsara BioCapital, Sheatree Capital…
